Ovarian aging: role of Pituitary-Ovarian axis hormones and ncRNAs in regulating ovarian mitochondrial activity
Soliqua 100/33 (active ingredients: insulin glargine and lixisenatide) subcutaneous injection Initial FDA Approval: 2016 Side Effect Update Date: May 28, 2025 Medication Description: Treats type 2 diabetes Updated Side Effects/Safety Information: A new warning section on Severe Gastrointestinal Adverse Reactions. An additional new warning about the risk of serious kidney injury caused by dehydration due to gastrointestinal adverse effects like diarrhea and vomiting
However, GLP-1 drugs were associated with a slightly higher rate of uveitis when compared with SGLT2i agents, which also conferred a reduced uveitis risk when compared with controls
Small, consistent changeslike eating enough protein, choosing fibre-rich foods, and including healthy fatscan make a meaningful difference in how satisfied you feel after eating
Whilst blood glucose improvements typically emerge within the first few days, significant weight loss and optimal glycaemic control generally require several weeks to months of consistent treatment
